These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9850036)

  • 21. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic non-small cell lung cancer: costs associated with disease progression.
    Fox KM; Brooks JM; Kim J
    Am J Manag Care; 2008 Sep; 14(9):565-71. PubMed ID: 18778171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic analyses and lung cancer.
    Vergnenègre A; Molinier L; Chouaïd C
    Monaldi Arch Chest Dis; 2001 Aug; 56(4):336-43. PubMed ID: 11770217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
    O'Donnell MP; Roizen MF
    Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical costs of smoking in the United States: estimates, their validity, and their implications.
    Warner KE; Hodgson TA; Carroll CE
    Tob Control; 1999; 8(3):290-300. PubMed ID: 10599574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of positron emission tomography/computed tomography in the management of advanced head and neck cancer.
    Kurien G; Hu J; Harris J; Seikaly H
    J Otolaryngol Head Neck Surg; 2011 Dec; 40(6):468-72. PubMed ID: 22420434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
    Decroisette C; Monnet I; Berard H; Quere G; Le Caer H; Bota S; Audigier-Valette C; Geriniere L; Vernejoux JM; Chouaid C;
    J Thorac Oncol; 2011 Mar; 6(3):576-82. PubMed ID: 21270669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The health care costs of smoking.
    Barendregt JJ; Bonneux L; van der Maas PJ
    N Engl J Med; 1997 Oct; 337(15):1052-7. PubMed ID: 9321534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer.
    Lowery WJ; Lowery AW; Barnett JC; Lopez-Acevedo M; Lee PS; Secord AA; Havrilesky L
    Gynecol Oncol; 2013 Sep; 130(3):426-30. PubMed ID: 23769759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience.
    Croghan IT; Offord KP; Evans RW; Schmidt S; Gomez-Dahl LC; Schroeder DR; Patten CA; Hurt RD
    Mayo Clin Proc; 1997 Oct; 72(10):917-24. PubMed ID: 9379693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.
    Wang YT; Huang G
    Eur J Radiol; 2012 Aug; 81(8):e903-9. PubMed ID: 22698711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.
    Smith TJ; Hillner BE; Neighbors DM; McSorley PA; Le Chevalier T
    J Clin Oncol; 1995 Sep; 13(9):2166-73. PubMed ID: 7666075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The economics of smoking: an overview of the international and New Zealand literature.
    Phillips D; Kawachi I; Tilyard M
    Pharmacoeconomics; 1993 Jun; 3(6):462-70. PubMed ID: 10146881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost analysis of lung cancer management in South Western Sydney.
    Kang S; Koh ES; Vinod SK; Jalaludin B
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):235-41. PubMed ID: 22498199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment patterns, health care utilization, and costs of ovarian cancer in Central and Eastern Europe using a Delphi panel based on a retrospective chart review.
    Kim K; Hernlund E; Hernadi Z; Révész J; Pete I; Szánthó A; Bodnar L; Madry R; Timorek-Lemieszczuk A; Bozanovic T; Vasovic S; Tomasevic Z; Zivaljevic M; Pazin V; Minárik T; Garanová H; Helpianska L; Justo N
    Int J Gynecol Cancer; 2013 Jun; 23(5):823-32. PubMed ID: 23666016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost of lung cancer in Alberta.
    Demeter SJ; Jacobs P; Chmielowiec C; Logus W; Hailey D; Fassbender K; McEwan A
    Can Respir J; 2007 Mar; 14(2):81-6. PubMed ID: 17372634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic considerations in the care of lung cancer patients.
    Desch CE; Hillner BE; Smith TJ
    Curr Opin Oncol; 1996 Mar; 8(2):126-32. PubMed ID: 8727305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic burden of lung cancer: A retrospective cohort study in South Korea, 2002-2015.
    Jeon SM; Kwon JW; Choi SH; Park HY
    PLoS One; 2019; 14(2):e0212878. PubMed ID: 30794674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.